[Multiple sclerosis at the time of world-wide use of disease modifying treatment].
The review discusses issues of multiple sclerosis (MS) management at the time of world-wide use of effective treatment - disease modifying treatment including the influence of the time of treatment start and adherence to treatment on its results, monitoring and treatment strategy of neurodegenerative disorders, problems of new trials, changes in MS course and significance of symptomatic treatment and rehabilitation. The discussion of many aspects is based on the data presented in the articles published in this special issue of the journal.
Gusev
E I
EI
Boĭko
A N
AN
D018450:Disease Progression; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010349:Patient Compliance; D017060:Patient Satisfaction; D016896:Treatment Outcome
D007155:Immunologic Factors; D018696:Neuroprotective Agents